XSHG
601567
Market cap2.89bUSD
Oct 09, Last price
13.36CNY
1D
-2.84%
1Q
-4.23%
Jan 2017
16.38%
IPO
163.41%
Name
Ningbo Sanxing Medical Electric Co Ltd
Chart & performance
P/E
14.74
P/S
1.31
EPS
0.91
Div yield, %
10.00%
Shrs. gr., 5y
0.17%
Rev. gr., 5y
15.08%
Revenues
14.31b
-1.97%
Net income
1.27b
-43.62%
CFO
1.82b
-0.80%
Dividend
Jun 10, 20260.145 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ningbo Sanxing Medical Electric Co.,Ltd. specializes in the global manufacturing and sale of power distribution and utilization systems. Its diverse product line includes electricity meters, transformers, compact substations, switchgear, and electric vehicle charging stations, among other essential power equipment. Beyond its core electrical offerings, the company also ventures into financial services such as leasing and factoring, provides consulting, and operates within the medical services sector. Established in 1986 and headquartered in Ningbo, China, the firm was formerly known as Ningbo Sanxing Electric Co., Ltd. before rebranding to its current name, Ningbo Sanxing Medical Electric Co.,Ltd., in October 2015.
Key people
Xi Lei Miao
Secretary of the Board, Director · since 2013
Director · since 2013
Jianjiang Zheng
Chairman of the Board
Wei Xiang
Independent Director
Mingyuan Zhang
Independent Director
Headquarters & legal address
浙江省宁波市鄞州工业园区（宁波市鄞州区姜山镇）
宁波市, ZJ 100000
CN
宁波市, ZJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||